San Francisco, CA · Founded 2020 · Privately Held (backing)
Developer of portable magnetic resonance imaging machines designed to offer diagnosis and interventions for neurological conditions. Neuro42 is based in San Francisco, CA and was founded in 2020. Its last known valuation is $135 million. It has raised $30 million across 2 recorded rounds; the latest was a $15.6 million early-stage round in Sep 2024.
Last price · $/share
—
Implied valuation
$135.0M
Total raised
$30.0M
Last round
Early Stage VC
Sep 2024
Cap table — not yet on record
Neuro42's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Neuro42 with a free account
·The complete investor list: 12 names
·Watch Neuro42: the Monday email on marks, rounds and moves